New perspectives for preventing hepatitis C virus liver graft infection
Open Access
- 1 June 2016
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 16 (6), 735-745
- https://doi.org/10.1016/s1473-3099(16)00120-1
Abstract
No abstract availableThis publication has 140 references indexed in Scilit:
- Chronic hepatitis C virus (HCV) disease burden and cost in the United StatesJournal of Hepatology, 2012
- Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factorNature Medicine, 2012
- A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivoJournal of Hepatology, 2011
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionGastroenterology, 2011
- In vivoevaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virusJournal of Hepatology, 2011
- Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human HepatocytesGastroenterology, 2010
- Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationThe Journal of Experimental Medicine, 2010
- Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activityProceedings of the National Academy of Sciences of the United States of America, 2009
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cellsNature, 2009